Therapeutic Parenteral Drugs, Two or More Administrations, Different Medications Template

Therapeutic drug - two or more administrations.

RMH: Medical history reviewed/updates
Allergies verified.
Weight: Weight

Indication: Indication/diagnosis
Related procedure: Related procedure

Administration 1: Administration 1
Time: Time
Drug name: Drug name
Dose: Dose
Route: Route
Site: Site/tooth area
Lot #: Lot #
Exp: Exp

Administration 2: Administration 2
Time: Time
Drug name: Drug name
Dose: Dose
Route: Route
Site: Site/tooth area
Lot #: Lot #
Exp: Exp

Administration 3 (if applicable): Administration 3 if applicable
Time: Time
Drug name: Drug name
Dose: Dose
Route: Route
Site: Site/tooth area

Vital Signs Monitoring:
Pre-administration vitals: BP/HR
Post-administration vitals: BP/HR

Patient Response: Patient response
Adverse reaction: None or describe.
Monitoring period: Monitoring period
Final status: Stable/status.

Patient instructions: Instructions reviewed.

Complications: None or describe.

Documentation requirements

D9612 is graded line-by-line — auditors confirm that each drug has a complete chain. A defensible note includes:

• Reviewed medical history with date — confirm allergies, current medications, pregnancy status if applicable, renal/hepatic concerns, and any drug-interaction screen relevant to today's medications
• Allergy verification — explicit "NKDA" or list. Do not skip this even when restated from intake
• Weight (kg) — required for any weight-based dosing (most steroids, antibiotics in pediatrics, ketorolac in select populations) and a defensible chart entry even when not weight-based
• Indication / diagnosis for each drug — name the clinical reason: "surgical site infection prophylaxis," "post-op edema control," "post-op nausea prophylaxis," "acute allergic reaction." A drug administered without a charted indication is a top denial reason
• Related procedure(s) — what surgical or therapeutic encounter the medication supports (e.g., "D7240 #32 impaction, IV moderate sedation D9239")
• Per-administration block — repeat for every drug:
  • Drug name (generic preferred, brand if patient-specific)
  • Dose with units (mg, mcg, mL, units)
  • Route (IM / IV / SubQ / submucosal / intraosseous / intranasal)
  • Site (e.g., "right deltoid IM," "left antecubital IV," "buccal vestibule submucosal #19 area")
  • Time of administration (clock time, not "during procedure")
  • Lot number and expiration date of the vial/ampule used — required for FDA-traceable medications and a near-universal Medicaid audit element
  • Operator initials — who actually pushed/injected the drug
• Pre- and post-administration vitals — BP, HR, SpO2, and respiratory rate when sedation-adjacent. Vitals at minimum at baseline and after each drug class (a single set "after everything" weakens the chain when one drug is later questioned)
• Patient response — therapeutic response (pain reduction, nausea relief, allergic-reaction resolution) and any adverse reaction. "No adverse reaction" is acceptable when true; "patient tolerated well" alone is not specific enough to defend against an audit
• Monitoring period and final status — duration of in-office observation after the last drug and the patient's status at discharge (stable, ambulatory, escorted)
• Patient instructions / discharge — what the patient was told, including signs to watch for, when to contact the office, and any home medication plan
• Complications — "none" is acceptable; describe in detail if any
• Provider signature and assistant/operator initials

The single most common audit failure on D9612 is a note that proves one drug was administered but not clearly the second — the code requires explicit documentation of each distinct medication, each with its own complete administration record. Default-normal autotext that lists drugs in a single line ("Cefazolin 1 g and Dexamethasone 8 mg given IM") will be down-coded to D9610 by carriers that audit.

Common denial reasons

The most common reasons D9612 is denied, downgraded, or audited:

• Drugs are part of the sedation plan — bundled into D9222/D9223/D9239/D9243 because the agents reported (e.g., midazolam + fentanyl, propofol + lidocaine) are integral to the sedation itself, not separate therapeutic medications
• Only one drug actually documented — the chart proves a single administration; the "two or more" requirement fails and the carrier down-codes to D9610 or denies entirely
• Same drug administered twice — two doses of the same medication (e.g., dexamethasone given pre- and post-op) is not D9612; it is D9610 once. D9612 specifically requires different medications
• Missing lot number / expiration — Medicaid MCOs and many commercial carriers explicitly require this on parenteral drug claims; absence is an automatic denial trigger on audit
• Missing site/route/time — even one missing element on one administration causes the line to fail
• No charted indication — drug given without a stated therapeutic reason; "patient comfort" alone does not satisfy
• Local anesthetic counted as a drug — D9215 cannot be one of the two; reporting local + steroid as "two drugs" under D9612 is a known miscoding pattern
• N2O counted as a drug — D9230 (nitrous) is also excluded; N2O + IM antibiotic is not D9612
• Oral medications counted — pre-op oral antibiotic + IM steroid is not D9612; the code requires parenteral (non-enteral) administration for all counted drugs
• Reporting D9610 and D9612 same DOS — mutually exclusive; carrier will pay one and deny the other
• Reported without a related procedure — billed in isolation with no surgical/endodontic/emergency context, the medical necessity is unclear and carriers flag for review
• Provider not credentialed for the route — IV administration billed by a provider whose state license does not permit IV therapy is a state-board issue beyond the carrier denial
• Duplicate billing across dental and medical claims — drugs paid on a hospital/facility claim resubmitted on dental ledger

Related templates